Related Experiment Video
Updated: Jun 1, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Parkinson's Disease: A Role for the Immune System
Dwight C German1, Todd Eagar, Patricia K Sonsalla
1Dwight C. German, Department of Psychiatry, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9070, USA. dwight.german@utsouthwestern.edu.
Current Molecular Pharmacology
|June 17, 2011
Summary
Parkinson's disease (PD) involves neurodegeneration and immune system dysfunction. This review explores the roles of microglia and T lymphocytes in PD progression and discusses immunotherapy for early detection and treatment.
Area of Science:
- Neuroscience
- Immunology
- Neuropathology
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons.
- Motor symptoms correlate with the degeneration of midbrain dopaminergic neurons, occurring after disease onset.
- Both innate and adaptive immune systems are implicated in PD's neurodegenerative process and progression.
Purpose of the Study:
- To review the neuropathology of Parkinson's disease.
- To focus on the involvement of innate immune cells (microglia) and adaptive immune cells (T lymphocytes).
- To discuss immunotherapy approaches for early PD detection and treatment.
Main Methods:
- Review of neuropathology in Parkinson's disease.
- Analysis of immune cell involvement (microglia and T lymphocytes).
- Discussion of a progressive rat model for studying immune system contributions to neurodegeneration.
Main Results:
- The review highlights the critical roles of microglia and T lymphocytes in PD pathogenesis.
- Animal models, particularly a progressive rat model, offer insights into immune system involvement across disease stages.
- Immunotherapy strategies are presented as potential avenues for early PD intervention.
Conclusions:
- Immune system components, including microglia and T lymphocytes, are integral to Parkinson's disease progression.
- Understanding the immune-mediated neurodegeneration is crucial for developing effective treatments.
- Immunotherapy holds promise for the early detection and management of Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:19Psychoneuroimmunology: Diabetes and Cancer
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
01:27Psychoneuroimmunology: Cardiovascular Disease
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...